C

Caregen Co Ltd
KOSDAQ:214370

Watchlist Manager
Caregen Co Ltd
KOSDAQ:214370
Watchlist
Price: 22 200 KRW -3.48% Market Closed
Market Cap: 1.1T KRW
Have any thoughts about
Caregen Co Ltd?
Write Note

Caregen Co Ltd
Note Receivable

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Caregen Co Ltd
Note Receivable Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Note Receivable CAGR 3Y CAGR 5Y CAGR 10Y
C
Caregen Co Ltd
KOSDAQ:214370
Note Receivable
â‚©950.2m
CAGR 3-Years
-9%
CAGR 5-Years
-10%
CAGR 10-Years
N/A
Yuhan Corp
KRX:000100
Note Receivable
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
SK Biopharmaceuticals Co Ltd
KRX:326030
Note Receivable
â‚©84.8m
CAGR 3-Years
N/A
CAGR 5-Years
16%
CAGR 10-Years
N/A
Hanmi Pharm Co Ltd
KRX:128940
Note Receivable
â‚©19.5B
CAGR 3-Years
52%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
S
Sam Chun Dang Pharm Co Ltd
KOSDAQ:000250
Note Receivable
â‚©6.7B
CAGR 3-Years
N/A
CAGR 5-Years
46%
CAGR 10-Years
N/A
C
Celltrion Pharm Inc
KOSDAQ:068760
Note Receivable
â‚©130.7m
CAGR 3-Years
-76%
CAGR 5-Years
N/A
CAGR 10-Years
-26%
No Stocks Found

Caregen Co Ltd
Glance View

Market Cap
1.1T KRW
Industry
Pharmaceuticals

Caregen Co., Ltd. engages in the development of cosmetic products. The company is headquartered in Anyang, Gyeonggi-Do. The company went IPO on 2015-11-17. The firm manufactures HSR CEs which used for improving facial wrinkles and strengthening protect wet under the brand name of Dermaheal, aquashines which used for keeping the shin whitening and promoting skin cells activation under the brand name of REVOFIL, HL CEs which used for treating hair loss, hair filler excell C'rums which used for promoting hair growth and preventing hair lose, LL CEs which used for promoting fat decomposition and prevent fat accumulation, hydra B5 Gels, ultra AW500s, eye filler masks, efficacy raw materials including growth facors and biomimetic peptides, and others. The firm distributes its products within domestic market and to overseas markets.

Intrinsic Value
13 853.64 KRW
Overvaluation 38%
Intrinsic Value
Price
C

See Also

What is Caregen Co Ltd's Note Receivable?
Note Receivable
950.2m KRW

Based on the financial report for Jun 30, 2024, Caregen Co Ltd's Note Receivable amounts to 950.2m KRW.

What is Caregen Co Ltd's Note Receivable growth rate?
Note Receivable CAGR 5Y
-10%

Over the last year, the Note Receivable growth was -1%. The average annual Note Receivable growth rates for Caregen Co Ltd have been -9% over the past three years , -10% over the past five years .

Back to Top